This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Here are the key takeaways from their conversation: Background and BCI Overview: Jim Pittman has over 30 years of experience in finance and privateequity, with a background in accounting and industry experience as a CFO and COO. Asset gathering without a clear strategy or focus can be a turn-off for investors.
As an emerging manager, you can celebrate not having the legacy issues and systems that blight old firms. Implementing bestpractices from the start shows intent and professionalism, and instils confidence that you are building a business where success is deliberate and repeatable. But be careful not to imbed your own early on.
strategic stake in 1315 Capital for approximately $70.5m, expanding its presence in the healthcare-focused privateequity sector. 1315 Capital, which manages over $1bn in assets, specialises in growth equity and buyouts within commercial-stage pharmaceutical outsourcing, medical technology, healthcare services, and wellness companies.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content